计算溶液所需的质量、体积或浓度。
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
H651198-10mg |
10mg |
期货 ![]() |
| |
H651198-25mg |
25mg |
期货 ![]() |
| |
H651198-50mg |
50mg |
期货 ![]() |
|
别名 | 氢化可他明 |
---|---|
英文别名 | HYDROCOTARNINE [WHO-DD] | 4-27-00-06395 (Beilstein Handbook Reference) | KBio1_001969 | KBioGR_002283 | BRN 0017283 | 1,3-Dioxolo[4,5-g]isoquinoline, 5,6,7,8-tetrahydro-4-methoxy-6-methyl- | NCGC00016666-01 | NCGC00016666-03 | 1,3-DIOXOLO(4,5-g)ISOQUINOLI |
规格或纯度 | ≥99% |
英文名称 | Hydrocotarnine |
生化机理 | 氢化可他宁是一种 Cbl 抑制剂,可导致炎症体介导的 IL-18 在结肠炎中分泌。氢化可他宁可增加糖酵解代谢中 GLUT1 的表达和细胞葡萄糖摄取量。氢化可他宁是一种提供镇痛作用的制剂。 |
储存温度 | -20°C储存 |
运输条件 | 超低温冰袋运输 |
产品介绍 |
Hydrocotarnine is a Cbl inhibitor, and results in inflammasome-mediated IL-18 secretion in colitis. Hydrocotarnine increases expression of GLUT1 and cellular glucose uptake in glycolytic metabolism. Hydrocotarnine acts as an agent that provides analgesic effect in cancer research In Vitro Hydrocotarnine is an analgesic agent (CRIN-2), with the patent ID of WO2011160016A2. Hydrocotarnine (10 μM; 1 h) elevates the secretion of IL-1β and IL-18, and (0.1-10 μM; 1 h) increases the global level of tyrosine-phosphorylated proteins in THP-1 cells. Hydrocotarnine (50 μM; 0-100 min) increases the glycolytic capacity and glycolytic reserve capacity in THP-1-derived macrophages. Hydrocotarnine (50 μM; 16 h) inhibits Cbl and increases the total GLUT1 protein in THP-1-derived macrophages. Hydrocotarnine is known to enhance the analgesic effect of opioids, and alleviates cancer pain. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot AnalysisCell Line: THP-1 cells Concentration: 0.1, 1, 10 μM Incubation Time: 1 hour Result: Induced p-Pyk2 loss and increased the level of tyrosine-phosphorylated proteins in a dose-dependent manner. In Vivo Hydrocotarnine (10 mg/kg/d; i.p.; 9 d) shows inhibitory effect on Cbl and results in increasing IL-18 levels, indicating that NLRP3 inflammasome activation is enhanced in mice . Hydrocotarnine (10 mg/kg/d; i.p.; 9 d) protects mice from DSS-induced colitis, with low scores of pathological evaluation of inflammation, epithelial defects, and crypt atrophy . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: DSS-induced colitis model in C57BL/6 mice (6-9 weeks old) Dosage: 10 mg/kg Administration: Intraperitoneal injection; once daily; 9 days while 2.5% DSS treatment began on day 1 and ended on day 7 Result: Significantly attenuated the weight loss of DSS-induced colitis mice compared to PBS-treated control mice, indicating that decreasing negative regulation of the NLRP3 inflammasome activation could attenuate colitis in an animal model. Form:Solid IC50& Target:Cbl |
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
---|
EC号 | 208-978-2 |
---|---|
分子类型 | 小分子 |
IUPAC Name | 4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinoline |
INCHI | InChI=1S/C12H15NO3/c1-13-4-3-8-5-10-12(16-7-15-10)11(14-2)9(8)6-13/h5H,3-4,6-7H2,1-2H3 |
InChi Key | XXANNZJIZQTCBP-UHFFFAOYSA-N |
Canonical SMILES | CN1CCC2=CC3=C(C(=C2C1)OC)OCO3 |
Isomeric SMILES | CN1CCC2=CC3=C(C(=C2C1)OC)OCO3 |
关联CAS | 550-10-7 |
PubChem CID | 3646 |
MeSH Entry Terms | hydrocotarnine;hydrocotarnine hydrobromide;hydrocotarnine hydrochloride;hydrocotarnine hydrochloride monohydrate |
分子量 | 221.25 |
溶解性 | DMSO : ≥ 100 mg/mL (451.98 mM) |
---|---|
分子量 | 221.250 g/mol |
XLogP3 | 1.600 |
氢键供体数Hydrogen Bond Donor Count | 0 |
氢键受体数Hydrogen Bond Acceptor Count | 4 |
可旋转键计数Rotatable Bond Count | 1 |
精确质量Exact Mass | 221.105 Da |
单同位素质量Monoisotopic Mass | 221.105 Da |
拓扑极表面积Topological Polar Surface Area | 30.900 Ų |
重原子数Heavy Atom Count | 16 |
形式电荷Formal Charge | 0 |
复杂度Complexity | 261.000 |
同位素原子数Isotope Atom Count | 0 |
定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
所有立体化学键的总数The total count of all stereochemical bonds | 0 |
共价键合单元计数Covalently-Bonded Unit Count | 1 |